American International Group, Inc. Longboard Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$18.89 - $26.06 $85,760 - $118,312	4,540 Added 58.63%	12,283 $265,000
Q4 2023 Feb 13, 2024	SELL	$3.68 - $6.5 $114 - $201	-31 Reduced 0.4%	7,743 $46,000
Q3 2023 Nov 13, 2023	BUY	$5.49 - $7.49 $1,515 - $2,067	276 Added 3.68%	7,774 $43,000
Q2 2023 Aug 04, 2023	BUY	$4.19 - $10.05 $31,416 - $75,354	7,498 New	7,498 $55,000

126

34.9M

28.9K

13.9K

Ticker LBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,586,000
Market Cap $815M
Description
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.